date:Jun 06, 2019
dose or greater cost were not associated with evidence, says the studys senior investigator, Dan Merenstein, MD, professor of family medicine and Director of research programs for the Department of Family Medicine at Georgetown University School of Medicine.
It may be counterintuitive to consumers, but we found that products with fewer strains and lower cost were more likely to be supported by evidence we could trace, he says.
However, consumers will have to do the legwork themselves to figure